Centocor regulatory update

Centocor Inc. (CNTO) Sweden approved the Malvern, Penn., company's ReoPro GPIIb/IIIa inhibitor to treat high-risk angioplasty, marking the product's first approval. ReoPro is a monoclonal antibody d...